Bio-Techne Corporation
Bio-Techne Corporation (TECH) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · TECH · as of Sep 30, 2025
Ownership Breakdown
597
Institutional Holders
▲ 29 vs Q2
$8.84B
Total Inst. Value
▲ $675.62M vs Q2
156.57M
Shares Outstanding
freeFloat 99.61%
158.91M
13F Shares Held
▲ 242,376 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
TECH largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC biological products, (no diagnostic substances) | 17.93M | 11.38% | 11.38% | $997.58B | Nov 7, 2025 | ▼ 505.9K |
BLACKROCK, INC. biological products, (no diagnostic substances) | 11.89M | 7.55% | 7.55% | $661.28B | Nov 12, 2025 | ▼ 284.1K |
MORGAN STANLEY biological products, (no diagnostic substances) | 7.24M | 4.59% | 4.59% | $402.64B | May 27, 2026 | ▲ 658.9K |
STATE STREET CORP biological products, (no diagnostic substances) | 5.75M | 3.65% | 3.65% | $320.06B | Nov 14, 2025 | ▼ 105.2K |
WELLINGTON MANAGEMENT GROUP LLP biological products, (no diagnostic substances) | 5.12M | 3.25% | 3.25% | $284.55B | Nov 14, 2025 | ▲ 3.98M |
GEODE CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 4.93M | 3.13% | 3.13% | $273.68B | Nov 12, 2025 | ▲ 864.7K |
INVESCO LTD. biological products, (no diagnostic substances) | 3.95M | 2.51% | 2.51% | $219.52B | Nov 13, 2025 | ▲ 283.3K |
PRICE T ROWE ASSOCIATES INC /MD/ biological products, (no diagnostic substances) | 3.35M | 2.13% | 2.13% | $186.37B | Nov 14, 2025 | ▼ 5.50M |
NEUBERGER BERMAN GROUP LLC biological products, (no diagnostic substances) | 3.31M | 2.10% | 2.10% | $183.97B | Nov 12, 2025 | ▲ 807.1K |
MAVERICK CAPITAL LTD biological products, (no diagnostic substances) | 3.01M | 1.91% | 1.91% | $167.59B | Nov 14, 2025 | ▲ 3.01M |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
29
Increased
+17.93M shares3
New Positions
first time holders17
Decreased
−9.95M shares0
Sold Out
fully exitedNet shares change (top 50)
+7.97M
+17.93M / −9.95M
Net new holders
+15
3 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
TECH insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
10
Buy transactions
20
Sell transactions
0.50
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Crouse Steven C. President - Diag & Spatial Bi | Jun 2, 2026 | Tax Withhold | 216 | $49.77 | $10.8K | 6.8K | Form 4 ↗ |
Herr Amy E. director | May 8, 2026 | Sale | 6,636 | $48.28 | $320.4K | 200 | Form 4 ↗ |
Hippel James CFO | May 5, 2026 | Tax Withhold | 56,955 | $56.68 | $3.23M | 153.7K | Form 4 ↗ |
Bohnen Shane SVP - General Counsel | May 5, 2026 | Tax Withhold | 7,055 | $56.68 | $399.9K | 7.2K | Form 4 ↗ |
Kelderman Kim Chief Executive Officer | May 5, 2026 | Tax Withhold | 23,951 | $56.68 | $1.36M | 65.8K | Form 4 ↗ |
Crouse Steven C. President - Diag & Spatial Bi | May 1, 2026 | Tax Withhold | 311 | $55.02 | $17.1K | 6.3K | Form 4 ↗ |
Kelderman Kim Chief Executive Officer | Apr 22, 2026 | Tax Withhold | 1,363 | $58.58 | $79.8K | 63.1K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Bio-Techne Corporation (TECH) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 0.39%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Bio-Techne Corporation is VANGUARD GROUP INC, holding approximately 17.93 million shares — equal to 11.38% of outstanding shares — as of September 30, 2025.
A total of 597 institutional investors currently hold TECH stock, with a combined institutional value of approximately $8.84 billion as of the most recent 13F filing period.
Frequently asked questions
TECH ownershipBio-Techne Corporation (TECH) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is VANGUARD GROUP INC with a 11.38% stake. Company insiders hold 0.39%. Data sourced from SEC Form 13F as of September 30, 2025.